Related Experiment Videos
Chromatographic studies of uremic plasma
The International Journal of Artificial Organs
|July 1, 1979
Summary
Researchers developed a simple method to separate toxic compounds in uremic serum using Sephadex G-15 chromatography. This technique revealed distinct peptide mixtures in uremic, acute renal failure, and chronic renal failure patients compared to normal plasma.
Area of Science:
- Biochemistry
- Nephrology
- Analytical Chemistry
Background:
- Uremia is associated with the accumulation of toxic retention compounds.
- Characterizing these compounds is crucial for understanding uremic toxicity.
- Existing methods for analyzing uremic serum components can be complex.
Purpose of the Study:
- To develop a simple, reproducible method for fractionating uremic serum.
- To identify and characterize potentially toxic retention compounds in uremia.
- To compare serum peptide profiles in normal, acute renal failure, and chronic renal failure patients.
Main Methods:
- Sephadex G-15 column chromatography for serum fractionation.
- Thin layer chromatography (TLC) for analyzing separated fractions.
- Analysis performed at ambient temperatures without prior deproteinization.
Main Results:
- The method successfully separated uremic serum into well-defined fractions.
- Each fraction primarily contained mixtures of peptides.
- Significant qualitative and quantitative differences were observed in peptide profiles between normal and uremic plasma.
- Distinct differences were also noted between acute and chronic renal failure patient plasma.
Conclusions:
- Sephadex G-15 chromatography is an effective technique for analyzing uremic serum components.
- Uremia alters serum peptide profiles, with variations observed in different renal failure stages.
- This method aids in characterizing potentially toxic retention compounds in uremia.